Page last updated: 2024-08-23

2,2',3,5',6-pentachlorobiphenyl and Anesthesia Related Hyperthermia

2,2',3,5',6-pentachlorobiphenyl has been researched along with Anesthesia Related Hyperthermia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pessah, IN; Ta, TA1

Other Studies

1 other study(ies) available for 2,2',3,5',6-pentachlorobiphenyl and Anesthesia Related Hyperthermia

ArticleYear
Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Neurotoxicology, 2007, Volume: 28, Issue:4

    Topics: Animals; Arginine; Calcium; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; In Vitro Techniques; Inhibitory Concentration 50; Malignant Hyperthermia; Muscle, Skeletal; Mutation; Polychlorinated Biphenyls; Protein Binding; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Swine; Tritium

2007